These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35579487)

  • 1. Brexpiprazole-Associated Pisa Syndrome (Pleurothotonus) in a Patient With Dementia.
    Nagai Y; Yamazaki T; Sugita T; Shibata N
    Clin Neuropharmacol; 2022 May-Jun 01; 45(3):72-73. PubMed ID: 35579487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pisa syndrome during aripiprazole treatment: a case report.
    Rota E; Bergesio G; Dettoni E; Demicheli CM
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):286-7. PubMed ID: 16846672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medication Adherence, Health Care Utilization, and Costs in Patients With Major Depressive Disorder Initiating Adjunctive Atypical Antipsychotic Treatment.
    Broder MS; Greene M; Yan T; Chang E; Hartry A; Yermilov I
    Clin Ther; 2019 Feb; 41(2):221-232. PubMed ID: 30616973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quetiapine Relieved Pisa Syndrome in Patient With Parkinson Disease.
    Zhao J; Wang Q; Sun H; Liu X; Leng B; Wang T
    Clin Neuropharmacol; 2020; 43(6):171-174. PubMed ID: 32991348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-induced Pisa syndrome (pleurothotonus): epidemiology and management.
    Suzuki T; Matsuzaka H
    CNS Drugs; 2002; 16(3):165-74. PubMed ID: 11888337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health Care Cost in Patients With Schizophrenia Treated With Brexpiprazole Versus Other Oral Atypical Antipsychotic Therapy.
    Yan T; Greene M; Chang E; Houle CR; Waters HC; Tarbox MH; Broder MS
    Clin Ther; 2020 Jan; 42(1):77-93. PubMed ID: 31928831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-Dependent Effects of Lithium Treatment on the Aggravation of Antipsychotic-Induced Pisa Syndrome.
    Hsieh HT; Yeh YW
    Clin Neuropharmacol; 2020; 43(3):90-91. PubMed ID: 32384312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of brexpiprazole in acute management of psychiatric disorders: a meta-analysis of randomized controlled trials.
    Antoun Reyad A; Girgis E; Mishriky R
    Int Clin Psychopharmacol; 2020 May; 35(3):119-128. PubMed ID: 32141908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful switching of patients with acute schizophrenia from another antipsychotic to brexpiprazole: comparison of clinicians' choice of cross-titration schedules in a post hoc analysis of a randomized, double-blind, maintenance treatment study.
    Correll CU; Shi L; Weiss C; Hobart M; Eramo A; Duffy RA; Weiller E; Baker RA
    CNS Spectr; 2019 Oct; 24(5):507-517. PubMed ID: 30306884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pisa syndrome induced by switching of a choline-esterase inhibitor treatment from donepezil to galantamine: a case report.
    Mimura Y; Kurose S; Takata T; Tabuchi H; Mimura M; Funayama M
    BMC Neurol; 2020 May; 20(1):183. PubMed ID: 32404068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of brexpiprazole adjunctive treatment for major depressive disorder.
    Sussman M; Yu J; Kamat SA; Hartry A; Legacy S; Duffy R; Aigbogun MS
    J Affect Disord; 2017 Jan; 207():54-62. PubMed ID: 27693466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversible Pisa syndrome (pleurothotonus) due to the cholinesterase inhibitor galantamine: case report.
    Cossu G; Melis M; Melis G; Maccioni E; Putzu V; Catte O; Putzu PF
    Mov Disord; 2004 Oct; 19(10):1243-4. PubMed ID: 15389998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brexpiprazole in the treatment of schizophrenia and agitation in Alzheimer's disease.
    Stummer L; Markovic M; Maroney M
    Neurodegener Dis Manag; 2020 Aug; 10(4):205-217. PubMed ID: 32618483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of anticholinergics and neuroleptic dose reduction on neuroleptic-induced pleurothotonus (the Pisa syndrome).
    Suzuki T; Hori T; Baba A; Abe S; Shiraishi H; Moroji T; Piletz JE
    J Clin Psychopharmacol; 1999 Jun; 19(3):277-80. PubMed ID: 10350039
    [No Abstract]   [Full Text] [Related]  

  • 15. Clozapine-Associated Pisa Syndrome: A Case Report of an Acute Reaction in a Bipolar Patient.
    Santos HC; Oliveira J; Vieira AS; Pereira J
    Clin Neuropharmacol; 2021 Nov-Dec 01; 44(6):222-224. PubMed ID: 34654016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Switching from Inadequate Adjunctive or Combination Treatment Options to Brexpiprazole Adjunctive to Antidepressant: An Open-Label Study on the Effects on Depressive Symptoms and Cognitive and Physical Functioning.
    Fava M; Okame T; Matsushima Y; Perry P; Weiller E; Baker RA
    Int J Neuropsychopharmacol; 2017 Jan; 20(1):22-30. PubMed ID: 27784751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brexpiprazole: A Review in Schizophrenia.
    Garnock-Jones KP
    CNS Drugs; 2016 Apr; 30(4):335-42. PubMed ID: 27023789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholinergic-dopaminergic imbalance in Pisa syndrome.
    Villarejo A; Camacho A; García-Ramos R; Moreno T; Penas M; Juntas R; Ruiz J
    Clin Neuropharmacol; 2003; 26(3):119-21. PubMed ID: 12782913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brexpiprazole: a new leaf on the partial dopamine agonist branch.
    Hope J; Castle D; Keks NA
    Australas Psychiatry; 2018 Feb; 26(1):92-94. PubMed ID: 29017334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pisa syndrome, or pleurothotonus.
    Pilette WL
    Am J Psychiatry; 1987 Jul; 144(7):969-70. PubMed ID: 2886064
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.